Chip scale photonics technology is developing rapidly for diverse applications, from communication and computation to various types of sensing. The Levy group has pioneered diverse advanced chip scale photonic technologies, including for ...

  Step One: “Smart” micro - or nano-particles carrying inhibitors of the gene machinery in pathogens are developed. Step Two: In the presence of biomarkers, the inhibiting agents are released, leading to the localized destruction of the ...

  Professors Willner and Pikarsky are developing masks and possible ventilation systems that will contain virus neutralizing properties. They have undertaken the development of matrices that neutralize pathogens which can be incorporated into ...

  Pneumonia caused by the new coronavirus SARS-CoV-2 has caused serious damage to people’s lives and health. The initial route of infection is the binding of the spike protein (S protein) of the virus to the angiotensin-converting enzyme 2 ...

  This study will test the hypothesis that treatment with a peptide comprising five units (5-MER), which is administered by injection or oral delivery, will substantially reduce chronic inflammation of the upper respiratory tract and lungs, thus ...

  Early, rapid, mobile, widespread and cheap detection of viral infection in humans is crucial in the battle against Corona, the worst epidemic of the last one hundred years. The virus is characterized by a specific single strand RNA and its ...

  The goal of this project is to develop environmentally-friendly and non-toxic coating that would prevent the adhesion of viruses. My research group developed a peptide-based coating that prevents adhesion of proteins to surfaces when then ...

  We compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. Molecular dynamics simulations reveal a temporal dimension of ...

Our laboratory has previously generated fusion proteins of a wide range of viral entry receptors. Among these is ACE2, a membrane-bound enzyme which also serves as the entry receptor for the SARS virus. Study of the novel coronavirus discovered ...

Increased blood vessel permeability and vascular leak are a final common pathway in severe influenza and other fatal diseases, such as MERS, Ebola, Coronavirus and sepsis. We have developed at the Hebrew U.- Hadassah Medical School( Prof. ...

Our group has published a lot of work on the SARS Coronavirus. We were the first to characterize an important protein in the virus that has a very unusual structure and sequence (E protein). Moreover, this protein was unique to SARS and was not ...

Our Innovative Approach The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery & repositioning. Using advanced comparative genomic, and data integration, our lab has been ...

We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time. Our method is based on a kit which identifies specifically the viral RNA biomarker. The test is characterized by reliability, ...

COVID-19 Pepticom is implementing its proprietary core AI technology on various Coronavirus proteins and the ACE2 to identify novel inhibitors that can fight Sars Cov2. They are currently looking for partners to validate and develop these ...

COVID-19 Enlivex:  Has developed a medication that could help treat severe symptoms of covid-19 including catastrophic organ failure. Company Name Enliex Year Company was Founded 2005 About the Company Enlivex Therapeutics R&D, a ...